Nomination procedure
In 2006 the Young Investigator Award was named after Liliane Striker in recognition of her many contributions to renal research. The Liliane Striker Young Investigator Award was established to encourage excellence in the area of renal pathology research by young investigators. The recipient will be selected from those nominated based on the quality of his/her abstract(s) submitted to the ASN or USCAP Annual Meeting. Awards in the amount of $500 (US) will be presented at the ASN and USCAP Meetings.
Qualifying criteria and nomination procedure
The nominee must be the first author on the abstract and be nominated by a member of the RPS. The RPS member does not need to be a co-author of the submitted abstract but should be from the same institution as the nominee. Renal fellows or junior faculty with less than 3 years of appointment are eligible. Nominations should be submitted to Chair of the Nominating and Award Committee.
Previous Recipients
|
Year |
Recipients |
Topic |
Sponsor |
|
|
2010 |
Miguel Fernando Palma Diaz |
Correlation of histologic findings with donor specific antibodies (DSA) in C4d positive renal allograft biopsies during the early post-transplant period |
Charlie Alpers |
|
2009 |
Mariam van Groningen |
Epithelial to mesenchymal transition in early renal transplant fibrosis |
Jan Bruijn |
|
|
|
2008 |
Yiqin Zuo, M.D., Ph.D. |
Synergistic Effects of AcSDKP and Angiotensin Receptor Blocker on Repressing Plasminogen Activator Inhibitor-1 (PAI-1) Expression in Early Renal Interstitial Fibrosis |
A. Fogo |
|
|
|
2007 |
Joris J. Roelofs |
Lysosomes are required by mesangial cells to participate in renal AL-amyloidogenesis |
J. Weening |
|
|
|
2006 |
John Keeling |
MMP-7 expression and the accumulation of tenascin in light cain deposition disease mesangial nodules |
G. Herrera |
|
|
|
2005 |
Xiubin Liang |
Thymosin 4 is a marker or possibly even a contributor to glomerulosclerosis. |
A. Fogo |
|
|
|
2004 |
Hai-Chun Yang |
Absence of integrin avb6 decreases interstitial fibrosis but worsens glomerulosclerosis in remnant kidney mice |
A. Fogo |
|
|
|
2002- 2003 |
Adrian A. Suarez |
Altered gene transcript profiles in congenitally obstructed human kidneys |
H. Liapis |
|
|
|
2001 |
Michael Eikmans |
Molecular diagnostics of renal diseases |
J. Bruijn |
|
|
|
2000 |
Li-jun Ma |
Regression of glomerulosclerosis in aging by angiotensin II Type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1). |
A. Fogo |
|
|
|
1999 |
Peter Heeringa |
Expression of chemokines in murine crescentic glomerulonephritis |
J.C. Jennette |
|
|
|
1998 |
Glen Markowitz |
Polycystin-2 expression is developmentally regulated |
Vivette D'Agati |
|
|
|
1997 |
Hitendra S. Jethwa |
Variable region gene selection in murine anti-myeloperoxidase (MPO) autoantibodies |
J.C. Jennette |
|
|
|
1997 |
Jorge Isaac |
In vitro AL-amyloid formation by human mesangial cells (HMCs) is attenuated by chloroquine. |
G. Herrera |
|
|
|
1996 |
Tsuyoshi Oikawa |
Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition |
A. Fogo |
|
|
|
1996 |
Hugh B. Carey |
Early hypoxia induced loss of Na, K-ATpase polarity in proximal tubules is associated with specific calpain regulated fodrin processing. |
M. Kashgarian |
|
|
|
1995 |
Shane Meehan |
Expression of TIA-1, a cytoxic I cell protein in renal allograft rejection |
R. B. Colvin |